SH

Shabista Hasan

Active Director Director DIN 09001267
DIN 09001267 First appointment Dec 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Shabista Hasan

Data last updated:

Shabista Hasan is a Director at Brennon Drugs Private Limited (since 2020). The company operates in Chemicals. Brennon Drugs Private Limited reported revenue of ₹18.4 Lakh (FY 2024).

DIN 09001267
Primary Designation Director
Industry Chemicals
First Appointment 18 Dec 2020
Oldest Company Age 5 yrs
Largest company Brennon Drugs Private Limited · ₹18.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brennon Drugs Private Limited U24110MH2020PTC352133
Director18 Dec 20202020₹18.4 Lakh (FY 2024)Active

Board colleagues of Shabista Hasan

NameDINCompanyDesignation
Maisara Zuberi09001266Brennon Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Brennon Drugs Private Limited
Premium access

Shareholding and investment profile for Shabista Hasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shabista Hasan

Shabista Hasan currently holds 1 directorship: Brennon Drugs Private Limited (Director, since 18 Dec 2020, revenue ₹18.4 Lakh (FY 2024)).

Shabista Hasan was first appointed on 18 Dec 2020 as Director at Brennon Drugs Private Limited.

The current boards of Shabista Hasan's companies include Maisara Zuberi (Brennon Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available